Why enroll in My VYVGART Path?

My VYVGART Path is a patient support program that pairs you with a dedicated Nurse Case Manager (NCM), who can help you navigate insurance, offer resources, talk through your challenges, and more.

Information provided by the NCM is not intended or implied to be a substitute for professional medical advice, diagnosis, or treatment. Always consult with a qualified and licensed physician or other healthcare provider regarding your medical condition, treatment, and healthcare needs.

My VYVGART Path may help improve access to treatment

What to expect throughout your treatment journey

See how My VYVGART Path is here to guide you throughout each step of the journey listed below.

Map showing 4 steps: My VYVGART Path enrollment, cost and coverage confirmation, treatment begins, and ongoing support Map showing 4 steps: My VYVGART Path enrollment, cost and coverage confirmation, treatment begins, and ongoing support Map showing 4 steps: My VYVGART Path enrollment, cost and coverage confirmation, treatment begins, and ongoing support

There are 2 options to enroll once your doctor has prescribed you VYVGART Hytrulo:

Option 1

Complete the My VYVGART Path enrollment form.

Option 2

Speak with your doctor and ask to be enrolled in My VYVGART Path.

 

Once enrolled in My VYVGART Path, you will receive a call from an NCM to welcome you into the program. A welcome kit will be mailed to you that includes a wide range of helpful resources.

An NCM works with your support team to help you and your doctor’s office navigate the insurance process and understand your plan’s coverage requirements for VYVGART Hytrulo.

The My VYVGART Path team will complete a benefits investigation to help provide you with personalized information about your insurance coverage, potential financial assistance programs, and confirm if you are eligible for lower out of out-of-pocket costs through the VYVGART Copay Program.

  

If you are eligible for the VYVGART Copay Program. you may pay as little as $0 for VYVGART Hytrulo and related administration costs.a

aEligible commercially insured patients may pay as little as $0 for VYVGART and may receive a maximum benefit of $25,000 per calendar year for their eligible out-of-pocket costs for the drug and drug administration. Persons residing in MA and RI are not eligible for financial assistance related to administration costs. Please see full Terms and Conditions.

  

As you begin treatment, an NCM is here to answer questions you and your loved ones may have. They can help with things like:

  • Explaining how VYVGART Hytrulo works
  • Helping you understand the treatment process
  • Providing guidance to help discuss treatment goals with your doctor
  • Sharing educational information and resources on the injection process
  • Learning about additional education and resources, if you are self-injecting with the VYVGART Hytrulo prefilled syringe
6.1-NCM full illlustration-D

NCM assistance continues through your VYVGART Hytrulo treatment process, providing guidance and teaching you about tracking your abilities, which can inform your discussions with your doctor.

MVP logo

Enroll in My VYVGART Path

There are 2 options to enroll once your doctor has prescribed you VYVGART Hytrulo:

Option 1

Complete the My VYVGART Path enrollment form.

Option 2

Speak with your doctor and ask to be enrolled in My VYVGART Path.

Once enrolled in My VYVGART Path, you will receive a call from an NCM to welcome you into the program. A welcome kit will be mailed to you that includes a wide range of helpful resources.

Image of Margaret, a Nurse Case Manager
Image of Margaret, a Nurse Case Manager
It’s a great feeling to educate patients about a treatment option.

Margaret

Nurse Case Manager

Resources to get you started

What’s Next Guide

The What’s Next Guide outlines next steps as you begin your journey with VYVGART Hytrulo.

My VYVGART Path brochure

See how the My VYVGART Path Patient Support Program can empower you on your treatment journey.

VYVGART Co-pay Program brochure

If you have commercial or private insurance, you may be eligible for assistance through the VYVGART Co-pay Program.


Have questions? Call 1-833-VYV-CIDP (1-833-898-2437) to speak with an educator about CIDP, how VYVGART Hytrulo works, study results, cost and coverage, and more.

Do not take VYVGART HYTRULO if you are allergic to efgartigimod alfa, hyaluronidase, or any of the ingredients in VYVGART HYTRULO. VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

Before taking VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:

  • have an infection or fever.
  • have recently received or are scheduled to receive any vaccinations.
  • have any history of allergic reactions.
  • have kidney (renal) problems.
  • are pregnant or plan to become pregnant. It is not known whether VYVGART HYTRULO will harm your unborn baby.
    • Pregnancy Exposure Registry. There is a pregnancy exposure registry for women who use VYVGART HYTRULO during pregnancy. The purpose of this registry is to collect information about your health and your baby. Your healthcare provider can enroll you in this registry. You may also enroll yourself or get more information about the registry by calling 1-855-272-6524 or going to VYVGARTPregnancy.com
  • are breastfeeding or plan to breastfeed. It is not known if VYVGART HYTRULO passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

VYVGART HYTRULO can cause side effects which can be serious, including:

  • Infection. VYVGART HYTRULO may increase the risk of infection. If you have an active infection, your healthcare provider should delay your treatment with VYVGART HYTRULO until your infection is gone. Tell your healthcare provider right away if you get any of the following signs and symptoms of an infection:
    • fever
    • chills
    • frequent and painful urination
    • cough
    • pain and blockage of nasal passages
    • wheezing
    • shortness of breath
    • sore throat
    • excess phlegm
    • nasal discharge
  • Allergic reactions (hypersensitivity reactions). VYVGART HYTRULO can cause allergic reactions that can be severe. These reactions can happen during, shortly after, or weeks after your VYVGART HYTRULO injection. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of an allergic reaction:
    • rash
    • swelling of the face, lips, throat, or tongue
    • shortness of breath
    • hives
    • trouble breathing
    • low blood pressure
    • fainting
  • Infusion or injection-related reactions. VYVGART HYTRULO can cause infusion or injection-related reactions. These reactions can happen during or shortly after your VYVGART HYTRULO injection. Tell your healthcare provider if you have any of the following symptoms of an infusion or injection-related reaction:
    • high blood pressure
    • chills
    • shivering
    • chest, stomach, or back pain

The most common side effects of VYVGART HYTRULO include respiratory tract infection, headache, urinary tract infection, and injection site reactions.

These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is VYVGART HYTRULO® (efgartigimod alfa and hyaluronidase-qvfc)?

VYVGART HYTRULO is a prescription medicine used to treat adults with chronic inflammatory demyelinating polyneuropathy (CIDP).

It is not known if VYVGART HYTRULO is safe and effective in children.

Please see full Prescribing and Patient Information for VYVGART HYTRULO.

Dosage forms and strengths:

VYVGART Hytrulo is available as a single-dose subcutaneous injection containing: 200 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per prefilled syringe, or 180 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per vial.

Do not take VYVGART HYTRULO if you are allergic to efgartigimod alfa, hyaluronidase, or any of the ingredients in VYVGART HYTRULO. VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

Before taking VYVGART HYTRULO, tell your healthcare provider about all of your medical conditions, including if you:

  • have an infection or fever.
  • have recently received or are scheduled to receive any vaccinations.
  • have any history of allergic reactions.
  • have kidney (renal) problems.
  • are pregnant or plan to become pregnant. It is not known whether VYVGART HYTRULO will harm your unborn baby.
    • Pregnancy Exposure Registry. There is a pregnancy exposure registry for women who use VYVGART HYTRULO during pregnancy. The purpose of this registry is to collect information about your health and your baby. Your healthcare provider can enroll you in this registry. You may also enroll yourself or get more information about the registry by calling 1-855-272-6524 or going to VYVGARTPregnancy.com
  • are breastfeeding or plan to breastfeed. It is not known if VYVGART HYTRULO passes into your breast milk.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

VYVGART HYTRULO can cause side effects which can be serious, including:

  • Infection. VYVGART HYTRULO may increase the risk of infection. If you have an active infection, your healthcare provider should delay your treatment with VYVGART HYTRULO until your infection is gone. Tell your healthcare provider right away if you get any of the following signs and symptoms of an infection:
    • fever
    • chills
    • frequent and painful urination
    • cough
    • pain and blockage of nasal passages
    • wheezing
    • shortness of breath
    • sore throat
    • excess phlegm
    • nasal discharge
  • Allergic reactions (hypersensitivity reactions). VYVGART HYTRULO can cause allergic reactions that can be severe. These reactions can happen during, shortly after, or weeks after your VYVGART HYTRULO injection. Tell your healthcare provider or get emergency help right away if you have any of the following symptoms of an allergic reaction:
    • rash
    • swelling of the face, lips, throat, or tongue
    • shortness of breath
    • hives
    • trouble breathing
    • low blood pressure
    • fainting
  • Infusion or injection-related reactions. VYVGART HYTRULO can cause infusion or injection-related reactions. These reactions can happen during or shortly after your VYVGART HYTRULO injection. Tell your healthcare provider if you have any of the following symptoms of an infusion or injection-related reaction:
    • high blood pressure
    • chills
    • shivering
    • chest, stomach, or back pain

The most common side effects of VYVGART HYTRULO include respiratory tract infection, headache, urinary tract infection, and injection site reactions.

These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is VYVGART HYTRULO® (efgartigimod alfa and hyaluronidase-qvfc)?

VYVGART HYTRULO is a prescription medicine used to treat adults with chronic inflammatory demyelinating polyneuropathy (CIDP).

It is not known if VYVGART HYTRULO is safe and effective in children.

Please see full Prescribing and Patient Information for VYVGART HYTRULO.

Dosage forms and strengths:

VYVGART Hytrulo is available as a single-dose subcutaneous injection containing: 200 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per prefilled syringe, or 180 mg/mL of efgartigimod alfa and 2,000 U/mL of hyaluronidase per vial.